On the other hand, 177Lu-PSMA-617 targets prostate-specific membrane antigen (PSMA), a cell-surface protein enriched in prostate cancer, which is used to treat metastatic prostate cancer (52). The gene discussed is FOLH1; the disease is Familial prostate cancer.